Skip to content

Clinical trial to confirm the safety and effectiveness of three-dimensional radiotherapy planning system software (CQL/3D-RTPS/D)

Clinical trial to confirm the safety and effectiveness of three-dimensional radiotherapy planning system software (CQL/3D-RTPS/D)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052005
Enrollment
Unknown
Registered
2021-10-12
Start date
2021-10-11
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumour

Interventions

3D radiotherapy planning system software group:No

Sponsors

Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Cases of head and neck, thoracoabdominal or pelvic tumors; 2. The case creation date is between January 1, 2019 and June 31, 2021; 3. The case planning is designed by eclipse radiotherapy planning system software; 4. The irradiation mode of case planning is VMAT; 5. The planned dose is 1.8Gy-2.2Gy.

Exclusion criteria

Exclusion criteria: The planned target region overlaps with the serial organ PRV.

Design outcomes

Primary

MeasureTime frame
Accuracy of dose distribution calculation;Planned target D95%;

Secondary

MeasureTime frame
Point dose calculation accuracy;

Countries

China

Contacts

Public ContactHu Honglin

Sichuan Provincial People's Hospital

ffq614@163.com+86 18981838375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026